Shanghai Bao Pharmaceuticals Co., Ltd. (HKG:2659)
Hong Kong · Delayed Price · Currency is HKD 14.31
-0.59 (-3.96%)
Sep 11, 2026, 4:08 PM HKT
HKG:2659 Revenue
Shanghai Bao Pharmaceuticals had revenue of 9.88M CNY in the half year ending June 30, 2026, with 562.31% growth. This brings the company's revenue in the last twelve months to 17.04M, down -63.48% year-over-year. In the year 2025, Shanghai Bao Pharmaceuticals had annual revenue of 49.16M with 697.99% growth.
Revenue (ttm)
17.04M CNY
Revenue Growth
-63.48%
P/S Ratio
246.82
Revenue / Employee
46.82K CNY
Employees
364
Market Cap
4.86B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 49.16M | 43.00M | 697.99% |
| Dec 31, 2024 | 6.16M | -770.00K | -11.11% |
| Dec 31, 2023 | 6.93M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.